Strengthening Health Financing Research to Advance Universal Health Coverage: Gaps,Opportunities,and Policy Imperatives for the Philippines

Abstract

Strengthening health financing research is critical to advancing universal health coverage in the Philippines. Despite increasing policy commitments, financing decisions are often shaped more by fiscal and political pressures than by systematic, evidence-based analysis. This commentary highlights persistent gaps in the country’s research ecosystem characterized by limited funding, data access constraints, and weak integration of research into policymaking, and argues that without robust, empirical evidence, health reforms risk being ineffective or inequitable. Drawing on regional examples, the paper outlines a five-point action agenda to institutionalize health financing research including prioritizing strategic research areas, expanding research capacities, enabling transparent data sharing, bridging research and policymaking, and securing sustainable, diversified funding. These recommendations aim to reposition research as a core pillar of health system governance and to support evidence-informed reforms that enhance financial protection and equity.

Introduction

Universal health coverage (UHC) remains a key policy objective for many low- and middle-income countries (LMICs), including those in Southeast Asia, as they strive to reform their health systems to be more equitable, affordable and accessible. ¹ Across the region, countries have adopted diverse approaches to health financing and its governance, shaped by their distinct political, economic, and institutional landscape. ² The resilience and adaptability of these health financing systems were further tested by the COVID-19 pandemic exposing significant gaps in provider payment mechanisms, financial incentives, and budget flexibility. ³ A crucial lesson from the crisis is that achieving a resilient health system requires not only political will and institutional capacity, but also agile financing mechanisms that enables timely resource mobilization including risk-sharing arrangements, upfront payments, and an accountable public financial management system.^{4 -6}

More recently, the Philippine health financing system has come under intense public scrutiny, casting doubt on the country’s capacity to sustain its UHC reforms. In April 2024, the Department Finance (DOF) ordered the Philippine Health Insurance Corporation (PhilHealth), the country’s state health insurer to return ₱89.9 billion in unused subsidies citing inefficiencies in fund utilization and weak execution of its spending mandates.^7,8 The unutilized funds were primarily intended to support premium subsidies for indirect contributors, such as indigents and informal sector workers, and its underutilization was attributed to several factors including delays in expanding benefit payments, low provider reimbursement rates, and bureaucratic bottlenecks in claims processing.^9,10 The 2025 National Budget subsequently allocated zero funding for PhilHealth, ¹¹ an unprecedented move that reflects both the government’s growing concern over PhilHealth’s capacity for strategic purchasing and the accumulation of high reserve funds. ¹² These developments underscore a deeper weakness in the country’s health financing governance, including the lack of timely and policy-relevant research to inform decisions on subsidy allocations, benefit design, and provider payments reforms. Without such evidence the country risks pursuing reactive, politically motivated measures that could erode the gains in UHC implementation.

We observed that the fundamental issue in health financing decisions in the Philippines are too often shaped by fiscal constraints and political pressures rather than by systematic, evidence-based policymaking.^13,14 In many cases, decisions rely heavily on managerial data such as utilization rates, expenditure tracking, or claims backlogs, which are useful for operational oversight but insufficient for assessing policy effectiveness or long-term system outcomes. What is often missing are empirical studies that establishes causal links between financing decisions and health outcomes. ¹⁵ For example, the discourse on PhilHealth’s fund utilization has been dominated by calls for stricter financial oversight, ¹⁶ yet with limited examination on whether existing budget allocations are optimal, equitable, or aligned with UHC goals. Effective reforms require more than ad hoc or reactive solutions, they must be guided by comparative evaluations of policy options that take into account complex trade-offs and reflect a broader societal consensus on how to move forward with the reform process. ¹⁷ Without a robust research ecosystem to evaluate the impact of subsidy allocations, premium contribution models, and provider payment mechanisms, policymakers risk enacting reforms that could undermine financial protection, distort incentives, and deepen health inequities.

Despite the gravity of these challenges, health financing policy research remains underdeveloped in the Philippines. While numerous studies focus on service delivery and health outcomes, there is a glaring gap in research on financial risk protection, provider payment models, and fund sustainability. ¹⁸ This lack of systematic research undermines the country’s ability to craft long-term, strategic financing policies that can withstand economic shocks and health crises.

Current Efforts to Strengthen Research Ecosystem

Recognizing the need for stronger research, several programs have been initiated to generate evidence and build research capacities. For instance, the Advancing Health through Evidence-Assisted Decisions with Health Policy and Systems Research (AHEAD-HPSR) Program of the Department of Health (DOH), aims to institutionalize evidence-informed health sector policies and promote a stronger research-to-policy pipeline. ¹⁹ Similarly, PhilHealth STUDIES (Supporting the Thrust for UHC through Data, Information and Knowledge Exchange Systems) was launched in 2015 ²⁰ with the vision of seeing “a thousand papers bloom” on social health insurance and health financing in the country, and funds research to inform PhilHealth’s policies. ²¹ Since its inception, the initiative has supported 30 research studies, 5 capacity-building activities, and 8 research dissemination fora to foster a culture of evidence-based decision-making. Likewise, to build implementation research capacities within the state insurance, ensuring that technical staff can generate and apply evidence to address UHC implementation challenges, the Local Evidence to Advance Decisions (LEAD) Program was implemented that capacitated over 134 technical staff in the last 5 years. ²⁰ More recently, the Philippine Institute for Development Studies (PIDS), a leading government think tank, has also established its Health Economics and Finance Program which aims to conduct cutting-edge, data-driven policy research to assist DOH and PhilHealth in effectively implementing UHC. ²² Clearly, these efforts mark a significant step forward, but their impact remains limited. Without institutional backing, sustained funding, and integration into policymaking processes, these initiatives risk becoming isolated academic exercises rather than transformative policy tools.

Regional examples, such as Thailand’s journey toward UHC offers a compelling case of how health financing research effectively supports health system reform. The implementation of its Universal Coverage Scheme (UCS) has long benefited from embedded research institutions like the Health Systems Research Institute, which actively shapes strategic purchasing decisions and benefit package design.^23,24 Additionally, sustained capacity development in health systems and policy research through the International Health Policy Program further reinforced evidence-informed governance in Thailand. ²⁵

These experiences hold important lessons for the Philippines, which face similar challenges in aligning research with reform. Drawing from such regional models, the Philippines’ emerging health financing research ecosystem, if adequately institutionalized and empowered, could not only accelerate national progress on UHC but also contribute meaningfully to broader regional efforts to promote evidence-driven health financing strategies. Active participation in cross-country dialogues and learning platforms such as the recently concluded INSPIRE (Inclusive, Sustainable, Prosperous and Resilient Health Systems in Asia and the Pacific) Health Forum organized by the Asian Development Bank, ²⁶ and bilateral policy exchanges, can facilitate mutual learning and transfer of good practices. As countries in the region navigate complex reforms in health financing, the Philippines can both learn from and contribute to these shared efforts by offering context-specific insights, fostering regional solidarity, and helping shape a more coordinated approach to advancing UHC.

Call to Action

To ensure that evidence, rather than fiscal or political expediency, guides health financing decisions, the Philippines must elevate health financing research as a central pillar in health policymaking. We recommend a coordinated, multi-pronged strategy built around 5 key actions:

• Prioritize strategic research areas. The DOH and PhilHealth must proactively commission studies on high-impact issues such as strategic purchasing, fund sustainability, claims efficiency, premium contribution models, and fraud detection mechanisms. These priorities should be consistently integrated into the National Unified Health Research Agenda (NUHRA) and aligned with the country’s UHC implementation goals to ensure sustained attention and immediate policy uptake.

• Expand and diversify research capacities. Building a robust research ecosystem demands swift expansion of partnerships with a broad range of actors beyond government. Collaboration with academic institutions, think tanks, development partners, and independent researchers should be scaled up to bring in diverse perspectives, technical expertise, and methodological rigor. Such diversity will sharply enhance the quality, credibility, and policy relevance of research outputs, enabling more informed and inclusive decision-making.

• Establish transparent and enabling data-sharing policies. The cumbersome and restrictive process of accessing administrative and claims data remains a major barrier to conducting meaningful research. To address this, clear, transparent, and standardized data-sharing protocols must be instituted, balancing privacy safeguards with the need for timely and accessible data. Regional practices offer useful insights: countries like Taiwan and South Korea have institutionalized access to comprehensive national health insurance databases for qualified researchers enabling continuous policy evaluation and improvement.^27,28 Adopting similar practices will allow the Philippines to empower independent analysis, drive policy innovation, strengthen accountability, and drive smarter financing reforms.

• Bridge research and policymaking. Research findings must not remain confined to academic journals or internal agency reports. Structured mechanisms for ongoing dialogues between researchers and policymakers must be institutionalized. This includes dedicated policy forums, technical working groups, and embedded research arrangements that ensure evidence directly and promptly informs decisions on benefit package design, and provider payment adjustments.

• Secure sustainable funding for health financing research. Dedicated funding streams are essential to support comprehensive, forward-looking studies that go beyond reactive, crisis-driven inquiries. To address funding constraints, leverage opportunities from the Department of Science and Technology (DOST) and the Department of Economy, Planning and Development (DEPDev), which have mandates to mainstream research within broader national agendas ensuring long-term support for the sustainable transformation of the country’s health financing system.

Conclusion

The health financing challenges facing the Philippines require more than reactive or short-term policy responses, they call for a strong foundation of evidence to guide sustainable and equitable reforms. Without a vibrant and well-supported health financing research ecosystem, the country risks making decisions that may be inefficient, misaligned with health outcomes, or inadvertently exacerbate health inequities. Moving forward, research must be institutionalized as a core pillar of governance and must include increasing investment in research, strengthening collaborative networks, and improving access to reliable, policy-relevant data. The progress of UHC in the Philippines will depend not only on political commitment, but also on the systematic generation and use of evidence to sustain and steer reforms toward equity and effectiveness. Ultimately, research must not bloom as mere academic output, but should serve as a driving force for building an efficient, equitable, and resilient health financing system for all Filipinos.